Literature DB >> 20641145

Critical parameters in blood processing for T-cell assays: validation on ELISpot and tetramer platforms.

Georgia Afonso1, Matthieu Scotto, Amédée Renand, Jeanette Arvastsson, Dominique Vassilieff, Corrado M Cilio, Roberto Mallone.   

Abstract

Assays detecting antigen (Ag)-specific T-cell responses in immune-mediated processes are increasingly employed to understand disease pathogenesis and immune staging. The quantity and quality of starting peripheral blood mononuclear cell (PBMC) preparations are important factors in the performance of such assays. We therefore compared final PBMC yield and function by modifying parameters at the blood drawing, storage and processing steps. While drawing blood in vacuum-driven tubes or syringes and separating PBMCs on density gradients using standard or membrane (Leucosep) tubesmade no difference, storing tubes for 18 h without any agitation led to PBMC preparations contaminated with granulocytes and decreased interferon (IFN)-gamma enzyme-linked immunospot (ELISpot) responses. Even agitated blood showed a trend towards reduced ELISpot responses and increased human leukocyte Ag (HLA) multimer readouts when stored for 18 h compared to 3 h. These changes were reduced by diluting blood prior to storage. Washing PBMCs with media containing 10% human serum increased PBMC yields by 40.5%, without affecting ELISpot responses and multimer counts. However, washes with > 10% human serum decreased multimer counts, with no additional improvement in PBMC yields. These findings may be relevant for optimizing and harmonizing PBMC processing procedures for T-cell assays.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20641145     DOI: 10.1016/j.jim.2010.05.005

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  15 in total

1.  Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore.

Authors:  Anke Harenberg; Sarah Begue; Audrey Mamessier; Sophie Gimenez-Fourage; Ching Ching Seah; Ai Wei Liang; Jun Li Ng; Xue Yun Toh; Sophia Archuleta; Annelies Wilder-Smith; Lynette P Shek; Anh Wartel-Tram; Alain Bouckenooghe; Jean Lang; Denis Crevat; Catherine Caillet; Bruno Guy
Journal:  Hum Vaccin Immunother       Date:  2013-07-09       Impact factor: 3.452

2.  The Center for HIV/AIDS Vaccine Immunology (CHAVI) multi-site quality assurance program for cryopreserved human peripheral blood mononuclear cells.

Authors:  Marcella Sarzotti-Kelsoe; Leila K Needham; Wes Rountree; John Bainbridge; Clive M Gray; Susan A Fiscus; Guido Ferrari; Wendy S Stevens; Susan L Stager; Whitney Binz; Raul Louzao; Kristy O Long; Pauline Mokgotho; Niranjini Moodley; Melanie Mackay; Melissa Kerkau; Takesha McMillion; Jennifer Kirchherr; Kelly A Soderberg; Barton F Haynes; Thomas N Denny
Journal:  J Immunol Methods       Date:  2014-06-05       Impact factor: 2.303

Review 3.  Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society.

Authors:  R Mallone; S I Mannering; B M Brooks-Worrell; I Durinovic-Belló; C M Cilio; F S Wong; N C Schloot
Journal:  Clin Exp Immunol       Date:  2010-10-05       Impact factor: 4.330

4.  HLA-B7-restricted islet epitopes are differentially recognized in type 1 diabetic children and adults and form weak peptide-HLA complexes.

Authors:  Matthieu Scotto; Georgia Afonso; Thomas Østerbye; Etienne Larger; Sandrine Luce; Cécile Raverdy; Giulia Novelli; Graziella Bruno; Céline Gonfroy-Leymarie; Odile Launay; François A Lemonnier; Søren Buus; Jean-Claude Carel; Christian Boitard; Roberto Mallone
Journal:  Diabetes       Date:  2012-10       Impact factor: 9.461

5.  Improvement of IFNg ELISPOT Performance Following Overnight Resting of Frozen PBMC Samples Confirmed Through Rigorous Statistical Analysis.

Authors:  Radleigh Santos; Alcinette Buying; Nazila Sabri; John Yu; Anthony Gringeri; James Bender; Sylvia Janetzki; Clemencia Pinilla; Valeria A Judkowski
Journal:  Cells       Date:  2014-12-24       Impact factor: 6.600

6.  Cytokine release assays for the prediction of therapeutic mAb safety in first-in man trials--Whole blood cytokine release assays are poorly predictive for TGN1412 cytokine storm.

Authors:  S Vessillier; D Eastwood; B Fox; J Sathish; S Sethu; T Dougall; S J Thorpe; R Thorpe; R Stebbings
Journal:  J Immunol Methods       Date:  2015-05-07       Impact factor: 2.303

7.  Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies.

Authors:  M Maziarz; W Hagopian; J P Palmer; C B Sanjeevi; I Kockum; N Breslow; Å Lernmark
Journal:  Genes Immun       Date:  2015-10-29       Impact factor: 2.676

8.  The Role of Physical Stabilization in Whole Blood Preservation.

Authors:  Keith H K Wong; Rebecca D Sandlin; Thomas R Carey; Kathleen L Miller; Aaron T Shank; Rahmi Oklu; Shyamala Maheswaran; Daniel A Haber; Daniel Irimia; Shannon L Stott; Mehmet Toner
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379

9.  Granulocytes affect double-strand break repair assays in primary human lymphocytes.

Authors:  Sandrine Lacoste; Ravi Bhatia; Smita Bhatia; Timothy R O'Connor
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

10.  The effects of storage temperature on PBMC gene expression.

Authors:  Jun Yang; Norma Diaz; Joseph Adelsberger; Xueyuan Zhou; Randy Stevens; Adam Rupert; Julia A Metcalf; Mike Baseler; Christine Barbon; Tomozumi Imamichi; Richard Lempicki; Louis M Cosentino
Journal:  BMC Immunol       Date:  2016-03-15       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.